Facebook
Twitter
LinkedIn
Forward
In th
|
As psychedelics become increasingly decriminalized in various cities and countries, and excitement builds among scientists, physicians, and the general public, it is likely that more individuals wi
|
Join us for an informative session designed to enhance your expertise in prescribing GLP1 medications for the treatment of obesity.
|
The 2024 Obesity Medicine Association (OMA) Annual Business Meeting hosted by Lydia Alexander, MD, MFOMA, President of the OMA.
|
This session will provide a practical guide to understanding and interpreting continuous glucose monitoring (CGM) data for healthcare providers managing patients with diabetes and obesity.
|
Discover how optimizing sleep can transform obesity medicine care and improve weight management outcomes.
|
Insulin resistance (IR) is a common biochemical abnormality in patients with excess adiposity, obesity, and its complications.
|
The number of non-nutritive sweeteners (NNS) available, both synthetic and natural, has increased rapidly in recent years.
|
This webinar will discuss the latest advances in the management of the pre/post Bariatric patient After attending this webinar, the participants will be able to describe the latest recommendations
|
In this part one of a three part series, discover the fusion of education and practical application in promoting healthy dietary pattern through culinary medicine.
|